Home | Welcome to Contract Pharma   
Last Updated Sunday, April 19 2015

Print

Breaking News

Gil Roth
September 7, 2011
Allows for import of Investigational Medicinal Products (IMPs) at Belfast facility  Read More »
Gil Roth
September 7, 2011
Peter Gray to retire, succeeded by CFO Ciaran Murray  Read More »
Gil Roth
September 6, 2011
Slater named dir. of consulting at Field technology firm  Read More »
Gil Roth
September 6, 2011
Potential milestones add up to $820 million for MAO-B inhibitor  Read More »
Gil Roth
September 6, 2011
Tuberculosis, malaria treatments at center of new deal   Read More »
September 2, 2011
PTC regains worldwide rights to ataluren  Read More »
September 2, 2011
Grant reimburses 20% of eligible R&D expenses  Read More »
September 1, 2011
Varian to fill the role on an interim basis  Read More »
September 1, 2011
Will focus on early stage clinical programs  Read More »
September 1, 2011
Shaw and Wargin to unveil new services  Read More »
September 1, 2011
Adds freeze-drying capacity for commercial cytotoxic manufacturing  Read More »
August 31, 2011
To serve as EVP and General Counsel  Read More »
August 31, 2011
Blomberg to assume responsibility for finance and administration  Read More »
August 31, 2011
3M to develop and sell nucleic acid test kits  Read More »
August 31, 2011
Will oversee U.S., UK, India facilities   Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On